Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.
As coronavirus concerns grow, Gladstone's virology experts are here to answer your questions, offer insight, provide context, and discuss the impacts of the outbreak on public health.
Gladstone virology experts are available for media interviews.
At Gladstone, we believe that basic science will be key for identifying potential drug targets and creating an effective vaccine. Both are sorely needed. Antivirals that can control coronavirus growth could have a huge impact not only on disease outcome but also on virus transmission from one person to another.
Assistant Director, Communications
Direct line: 415.734.5000
Vice President of Communications
Direct line: 415.734.2019
1 - 15 of 107 Results
Barbara Engelhardt moves her computational and statistics lab to GladstoneInstitutional News News Release Data Science and Biotechnology
Karin Pelka will leverage the innate immune system to find new ways to tackle cancer and other diseasesInstitutional News News Release Genomic Immunology
Study points to a potential new treatment that could prevent chronic complicationsNews Release Research (Publication) Neurological Disease Paz Lab
Gladstone researchers tracked mitochondria inside brain cells and uncovered a new recycling pathway that may be linked to diseaseNews Release Research (Publication) Parkinson’s Disease Neurological Disease Nakamura Lab
Gladstone researchers discover a fundamental mechanism that appears to speed the change of stem cells into other cell typesNews Release Research (Publication) Virology Weinberger Lab Stem Cells/iPSCs Chaturvedi
A new human organoid developed by Gladstone scientists mimics one of the key steps in early embryonic developmentNews Release Research (Publication) Cardiovascular Disease McDevitt Lab CRISPR/Gene Editing Stem Cells/iPSCs
Gladstone researchers fine-tuned CRISPR-Cas9 genome editing to work on human immune cells called monocytesNews Release Research (Publication) Data Science and Biotechnology Genomic Immunology Krogan Lab Marson Lab CRISPR/Gene Editing
New Gladstone research points to a mechanism driven by a protein associated with a higher risk of developing the diseaseNews Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab Single Cell